Former Trump Aide Announces Involvement in Medical Marijuana Startup
Last September, biopharmaceutical company C3 International quietly announced the launch of the company’s flagship pain management pill, Idrasil. Idrasil is a medical cannabis pill and C3 claims it’s the first standardized form of the drug. And to help develop policy and a marketing strategy for the pill, C3 International has enlisted the counsel of George Papadopoulos, fresh off his 14-day stint in the clink for lying to the FBI during their investigation of the Trump campaign’s possible collusion with Russia. On Tuesday, Papadopoulos announced he had joined the Board of Advisors of C3 International, Inc. on Twitter.
Disgraced Trump Campaign Aide Will Advise Medical Cannabis Startup on Product Marketing
It would take a long memory (by today’s standards) to remember that George Papadopoulos was one of the first of President Trump’s campaign advisors to go down as a result of the Mueller investigation. In fact, the same month C3 International announced the launch of Idrasil, September 2018, Papadopoulos was sentenced to 14 days in federal prison for lying to investigators in January 2017.
Papadopoulos served his time in December. Currently, he is on a 12-month supervised release, aka parole. But parole doesn’t prevent Papadopoulos from starring in a docuseries about